Tandem Diabetes Care (TNDM) Other Non Operating Income (2013 - 2026)
Tandem Diabetes Care (TNDM) posted Other Non Operating Income of $1.7 million for Q1 2026, up 113.16% on a QoQ basis from -$12.9 million in Q4 2025.
Tandem Diabetes Care (TNDM) Other Non Operating Income (2013 - 2026) Analysis & Trends
Tandem Diabetes Care's Other Non Operating Income history runs 14 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- Quarterly Other Non Operating Income changed N/A year-over-year to $1.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.8 million (down 349.57% YoY) and the FY2025 annual result came in at -$13.0 million, changed N/A from the prior year.
- Other Non Operating Income was $1.7 million for Q1 2026 at Tandem Diabetes Care, up from -$12.9 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $4.2 million in Q2 2023 and bottomed at -$12.9 million in Q4 2025.
- A 5-year average of $291538.5 and a median of $1.3 million in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income soared 687.76% — and 2025, when it plunged 1120.27%.
- Tandem Diabetes Care's Other Non Operating Income stood at $1.7 million in 2022, then jumped by 125.36% to $3.8 million in 2023, then plunged by 66.19% to $1.3 million in 2024, then plunged by 1120.27% to -$12.9 million in 2025, then surged by 113.16% to $1.7 million in 2026.
- Business Quant data shows TNDM's Other Non Operating Income at $1.7 million in Q1 2026, -$12.9 million in Q4 2025, and -$612000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Tandem Diabetes Care | 1.16 Bn | 587.46 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | -12.94 Mn |
| Jun 30, 2025 | -612,000.00 |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 3.48 Mn |
| Mar 31, 2024 | 2.15 Mn |
| Dec 31, 2023 | 3.75 Mn |
| Sep 30, 2023 | 816,000.00 |
| Jun 30, 2023 | 4.18 Mn |
| Dec 31, 2022 | 1.66 Mn |
| Sep 30, 2022 | 144,000.00 |
| Jun 30, 2022 | -711,000.00 |
| Mar 31, 2022 | -1.10 Mn |
| Dec 31, 2021 | -1.59 Mn |
| Sep 30, 2021 | -1.87 Mn |
| Jun 30, 2021 | -1.36 Mn |
| Mar 31, 2021 | -1.92 Mn |
| Dec 31, 2020 | -1.62 Mn |
| Sep 30, 2020 | -8.36 Mn |
| Jun 30, 2020 | -17.15 Mn |